Immunotherapy Achieves Complete Long-Term Remissions
of Advanced and Therapy-Resistant Cancers
The state-of-the-art, non-toxic Immunotherapy protocols of the Issels® Immuno-Oncology Centers are designed to restore the body’s own complex immune and defense mechanisms to recognize and eliminate cancer cells.
They are always highly personalized and can be combined with gene-targeted or special standard cancer therapies according to individual needs.
The Issels Treatment® Programs:
The integrative Issels® Immuno-Oncology system is the result of extensive clinical and scientific research and has become internationally known for its remarkable rate of complete long-term remissions of advanced and standard therapy-resistant cancers.
Issels® Immuno-Oncology is based on and an expansion of the comprehensive strategy developed at the world’s first hospital specializing in the treatment of advanced and standard-therapy resistant cancers with 120 beds solely dedicated to immunotherapy based cancer treatment. Immunotherapy is now considered the most advanced of all cancer treatments.
Our approach focuses with equal importance on both the tumor and the tumor microenvironment, which plays a pivotal role in disease progression or regression.
This integrative strategy has been shown to improve outcomes of all cancer types and stages. It distinguishes the Issels® Immuno-Oncology programs fundamentally from the mere administration of a vaccine, of a cell therapy or another monotherapy.
Our many years of experience with personalized immunotherapy and our results make the decisive difference for you.
Issels Doctors Provide Extensive Follow-Up Even After Tumor Remission
We invite you to find out more about our individualized immunotherapy protocols, use of effective alternative cancer treatments, and our extensive history in helping cancer patients achieve complete long-term remission over years, and even decades. We encourage you to watch Video Testimonials or watch videos from patients and cancer survivors at YouTube.
Thousands of patients* have received treatment and many of them have achieved long-term remission of the following, and many other late stage, cancers:
Adenocarcinoma, Bone Cancer, Brain Cancer, Breast Cancer, Cervical Cancer, Colon Cancer, Embryonal Teratoma, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Mediastinal Cancer, Melanoma, Optic Nerve Cancer, Osteoclastoma, Osteosarcoma, Ovarian Cancer, Rhabdomyosarcoma, Sarcoma, Squamous Cell Cancer, Stomach Cancer, Teratoma, Testicular Cancer, Thyroid Cancer, Uterine Cancer, and many other early and late stage cancers.
Affordability and Qualification
During the last two decades, many cancer patients on a global basis have been facing increasing difficulties regarding insurance coverage, rising co-pay, especially for the newly approved immunotherapy drugs, loss of precious time due to lengthy approval procedures for clinical trials, the risk of being placed into the placebo group, and many other problems.
In our endeavors to help cancer patients receive effective treatment, Issels Immuno-Oncology has devised a geo-logistical structure that makes cutting-edge cancer treatments considerably more affordable and available in a timely manner, without patients running the risk of being placed into the placebo group, nor having to forego the quality of a first class internationally accredited hospital and US based treatment facilities.
The Issels non-toxic immunotherapy with vaccine and cell therapies, as well as advanced gene-targeted cancer therapies, are administered by our experienced doctors whose expertise is reflected in the results you can witness by visiting our extensive library of patient video testimonials.
* DISCLAIMER: The extent of the response to treatment varies from patient to patient, even with a similar diagnosis, as the internal bodily environment is unique to each individual patient.